Celea Therapeutics
About
Technology stack
detected 2026-07-06No comments yet. Be the first to share your take.
What does Celea Therapeutics do?
Celea Therapeutics is a clinical-stage biopharmaceutical company focused on developing deupirfenidone, a novel therapeutic candidate for Idiopathic Pulmonary Fibrosis (IPF). The company is a founded entity of PureTech Health plc and aims to establish deupirfenidone as a new standard of care for IPF patients.
How much funding has Celea Therapeutics raised?
Celea Therapeutics has raised a total of $360M in funding. The most recent round on record is Funding Round.
Where is Celea Therapeutics headquartered?
Celea Therapeutics is headquartered in Boston, Massachusetts, USA.
What industry does Celea Therapeutics operate in?
Celea Therapeutics operates in Biotechnology, Pharmaceuticals, HealthTech, Biotech, Drug Discovery, Clinical Trials.
How many employees does Celea Therapeutics have?
Celea Therapeutics has approximately 83 people on record.
What is Celea Therapeutics's revenue?
StartupHub estimates Celea Therapeutics's annual revenue at $10.5M (range $5.7M to $31.9M, 71% confidence), based on comparable companies in the sector.
What is Celea Therapeutics's valuation?
StartupHub estimates Celea Therapeutics's effective valuation at $1.5B (range $900.0M to $2.2B, 25% confidence), based on comparable companies in the sector.